제품 세부정보
Features and Advantages
- Seamless Transition from Preclinical to Clinical: Same cell clone, process, and QC as GMP products.
- Enhanced Production Standards: AOF raw materials, pharma-grade excipients, Grade B+A (ISO 5) environment.
- Comprehensive Quality Control: Additional strict testing for process impurities, sterility, and mycoplasma.
- Cost-Effective Solution: GMP-comparable quality at an economical price for early development.
- Risk Mitigation: Enhanced safety through rigorous impurity control and comprehensive testing.
Synonym
DIF, TNF-alpha, TNFA, TNFSF2, cachexin, cachectin, TNFα
Source
Human TNF-alpha, premium grade (TNA-H4211) is expressed from human 293 cells (HEK293). It contains AA Val 77 - Leu 233 (Accession # P01375-1).
Predicted N-terminus: Val 77
It is produced under our rigorous quality control system that incorporates a comprehensive set of tests including sterility and endotoxin tests. Product performance is carefully validated and tested for compatibility for cell culture use or any other applications in the early preclinical stage.
GMP-TNAH23 is the GMP version of this TNA-H4211. These two proteins display indistinguishable performance profiles, thereby ensuring a seamless transition for end users from early preclinical stage to later clinical phases.Request for sequenceMolecular Characterization

Other Tags and Version Biotin & Other Labeled Version
This protein carries no "tag".
The protein has a calculated MW of 17.4 kDa. The protein migrates as 17 kDa±3 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.
Endotoxin
Less than 0.01 EU per μg by the LAL method / rFC method.
Host Cell Protein
<0.5 ng/µg of protein tested by ELISA.
Host Cell DNA
<0.02 ng/μg of protein tested by qPCR.
Sterility
Negative
Mycoplasma
Negative
Purity
>95% as determined by SDS-PAGE.
>95% as determined by SEC-MALS.
Formulation
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
Reconstitution
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
Storage
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- -20°C to -70°C for 24 months in lyophilized state;
- -70°C for 3 months under sterile conditions after reconstitution.
ACRO Quality Management System
Quality Description
ACRO's Research-grade products are suitable for a wide range of cell culture applications, particularly for research use in academic institutions. These products are sterilized by filtration, followed by lyophilization where applicable. Typical specifications include endotoxin levels of <0.01 EU/μg and purities >95%. Biological activity is calibrated against WHO/NIBSC standards when available.
ACRO's Premium-grade (Pre-GMP) products are characterized by their high quality and enhanced safety profiles, making them ideal for early-stage discovery and manufacturing processes in cell therapy companies. A key advantage is their seamless transition to corresponding GMP-grade versions. Biological activity is calibrated against WHO/NIBSC standards when available. Typical specifications include endotoxin levels of <0.01 EU/μg and purities >95%. In addition, rigorous testing is conducted to ensure the absence of mycoplasma, HCD, and HCP, thereby guaranteeing product safety.
고객님도 확인한 상품
데이터 표시
SDS-PAGE

Human TNF-alpha, premium grade on SDS-PAGE under reducing (R) and non-reducing (NR) conditions. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95% (With Star Ribbon Pre-stained Protein Marker).
SEC-MALS

The purity of Human TNF-alpha, premium grade (Cat. No. TNA-H4211) is more than 95% and the molecular weight of this protein is around 50-62 kDa verified by SEC-MALS.
Report
Bioactivity-CELL BASE

Human TNF-alpha, premium grade (Cat. No. TNA-H4211) induces cytotoxicity effect on the WEHI-13VAR cells in the presence of the metabolic inhibitor actinomycin D. The specific activity of Human TNF-alpha, premium grade is >2.00×10^7 IU/mg, which is calibrated against human TNF-alpha WHO International Standard (NIBSC code: 12/154) (QC tested).
Protocol
Neutralization assay shows that the cytotoxicity effect of human TNF-alpha, premium grade (Cat. No. TNA-H4211) was inhibited by increasing concentration of Adalimumab. The concentration of TNF-alpha used is 20 pg/mL. The IC50 is 8.48 ng/mL (Routinely tested).
Protocol
The NF-kB (Luc) HEK293 Reporter Cell was stimulated with serial dilutions of Human TNF-alpha, premium grade (Cat. No. TNA-H4211). The EC50 value of this effect is 0.5143 ng/mL (Routinely tested).
Protocol
Bioactivity-ELISA

Immobilized Human TNF-alpha, premium grade (Cat. No. TNA-H4211) at 1 μg/mL (100 μL/well) can bind Humira with a linear range of 0.1-2 ng/mL (QC tested).
Protocol
Immobilized Human TNF-alpha, premium grade (Cat. No. TNA-H4211) at 2 μg/mL (100 μL/well) can bind Human TNFR1, Fc Tag (Cat. No. TN1-H5251) with a linear range of 0.1-4 ng/mL (Routinely tested).
Protocol
Immobilized Human TNF-alpha, premium grade (Cat. No. TNA-H4211) at 5 μg/mL (100 μL/well) can bind Human TNFR2, His Tag (Cat. No. TN2-H5227) with a linear range of 0.039-0.313 μg/mL (Routinely tested).
Protocol
Bioactivity-SPR

Monoclonal Anti-TNF-alpha Antibody, Human IgG1 (13B8) (Cat. No. TNA-AM493) captured on Protein A Chip can bind Human TNF-alpha, premium grade (Cat. No. TNA-H4211) with an affinity constant of 0.267 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).
Protocol
Bioactivity-Stability

Cell-based assay demonstrates batch-to-batch consistency between Acro's GMP and PG TNF-alpha.
사용자 리뷰 댓글 남기기

배경 소개
프론티어 진행
- 영어 이름:
Tumor necrosis factor α
- 카테고리:
- 상장 의약품 수:
68 상세
- 임상 의약품 수:
74 상세
- 최고 개발 단계:
Approved
전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

















